Welcome to LookChem.com Sign In|Join Free

CAS

  • or

150-59-4

Post Buying Request

150-59-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

150-59-4 Usage

Description

Alverine is a tertiary amine with one ethyl and two 3-phenylprop-1-yl groups attached to the nitrogen. It is an antispasmodic that acts directly on intestinal and uterine smooth muscle, making it a pharmaceutical compound with potential applications in various medical treatments.

Uses

Used in Pharmaceutical Industry:
Alverine is used as an anticholinergic agent for the treatment of irritable bowel syndrome. It helps to alleviate symptoms by reducing muscle spasms in the intestines and uterus, providing relief to patients suffering from this condition.
Additionally, Alverine can be used as an antispasmodic agent in other medical applications where smooth muscle relaxation is required, such as in the treatment of gastrointestinal disorders or during certain surgical procedures.

Originator

Alverine citrate,Kemikos

Manufacturing Process

2 Methods of producing of alverine: 1. 3-Phenylpropylchloride reacted with ethylamine in the presence potassium hydroxide and N-ethyl-3,3'-diphenyldipropylamine (alverine) was obtained. 2. 3-Phenylpropenal reacted with ethylamine in the presence hydrogen and Pt as catalyst and BaSO4 and N-ethyl-3,3'-diphenyldipropylamine (alverine) was obtained. In practice it is usually used as citrate.

Therapeutic Function

Anticholinergic, Spasmolytic

Check Digit Verification of cas no

The CAS Registry Mumber 150-59-4 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 1,5 and 0 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 150-59:
(5*1)+(4*5)+(3*0)+(2*5)+(1*9)=44
44 % 10 = 4
So 150-59-4 is a valid CAS Registry Number.
InChI:InChI=1/C20H27N/c1-2-21(17-9-15-19-11-5-3-6-12-19)18-10-16-20-13-7-4-8-14-20/h3-8,11-14H,2,9-10,15-18H2,1H3

150-59-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name alverine

1.2 Other means of identification

Product number -
Other names ALVERINE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:150-59-4 SDS

150-59-4Downstream Products

150-59-4Related news

On‐demand treatment with Alverine (cas 150-59-4) citrate/simeticone compared with standard treatments for irritable bowel syndrome: results of a randomised pragmatic study09/30/2019

BackgroundIn routine practice, irritable bowel syndrome (IBS) symptoms are often difficult to be relieved and impair significantly patients’ quality of life (QoL). A randomised, double‐blind, placebo‐controlled study has shown the efficacy of alverine citrate/simeticone (ACS) combination for ...detailed

Clinical trial: the efficacy of Alverine (cas 150-59-4) citrate/simeticone combination on abdominal pain/discomfort in irritable bowel syndrome ‐ a randomized, double‐blind, placebo‐controlled study09/29/2019

Aliment Pharmacol Ther 31, 615–624SummaryBackground  Alverine citrate and simeticone combination has been used for almost 20 years in irritable bowel syndrome (IBS), but supportive scientific evidence of efficacy was limited.Aim  To evaluate the efficacy of alverine citrate and simeticone combi...detailed

An improved LC-MS/MS method for the quantification of Alverine (cas 150-59-4) and para hydroxy Alverine (cas 150-59-4) in human plasma for a bioequivalence study☆09/28/2019

A highly sensitive and selective high performance liquid chromatography-tandem mass spectrometry method was developed and validated for the quantification of alverine (ALV) and its active metabolite, para hydroxy alverine (PHA), in human plasma. For sample preparation, solid phase extraction of ...detailed

150-59-4Relevant articles and documents

Design and synthesis of alverine-based ionic liquids to improve drug water solubility

Fernández-Stefanuto,Esteiro,Santiago,Moreno,Palomar,Tojo

, p. 20428 - 20433 (2020)

Alverine [3-phenyl-N-(3-phenylpropyl)-N-ethylpropan-1-amine] is a widely known smooth muscle relaxant used to relieve cramps or spasms of the stomach and intestines. As a free base, alverine is a liquid practically insoluble in water while its commercialized form, alverine citrate, is a white solid that can form different crystalline forms. With the aim of increasing alverine water solubility while avoiding polymorphs, in this work, the design, total synthesis, and characterization of a series of new ionic liquids incorporating alverine as the cation were carried out. The selection of the most suitable anions for the active pharmaceutical ingredient-based ionic liquids (API-ILs) was performed calculating the ionic liquid solubility in water by using a priori the COSMO-RS computational tool. The computational analysis of the intermolecular interactions between water and the API-ILs allowed understanding the water solubility of these systems. All the new salts were found to be ionic liquids and their water solubility was shown to be significantly increased compared with the free drug alverine. The highest value was obtained for alverinium tosylate, with a value of 38.10 mg mL-1, 39937-fold higher than that of alverine. Compared to the commercialized drug alverine citrate, a slight increase in water-solubility was observed in all cases. This journal is

Photocatalytic Water-Splitting Coupled with Alkanol Oxidation for Selective N-alkylation Reactions over Carbon Nitride

Xu, Yangsen,Zhang, Zhaofei,Qiu, Chuntian,Chen, Shaoqin,Ling, Xiang,Su, Chenliang

, p. 582 - 589 (2020/12/09)

Photocatalytic water splitting technology (PWST) enables the direct use of water as appealing “liquid hydrogen source” for transfer hydrogenation reactions. Currently, the development of PWST-based transfer hydrogenations is still in an embryonic stage. Previous reports generally centered on the rational utilization of the in situ generated H-source (electrons) for hydrogenations, in which photogenerated holes were quenched by sacrificial reagents. Herein, the fully-utilization of the liquid H-source and holes during water splitting is presented for photo-reductive N-alkylation of nitro-aromatic compounds. In this integrate system, H-species in situ generated from water splitting were designed for nitroarenes reduction to produce amines, while alkanols were oxidized by holes for cascade alkylating of anilines as well as the generated secondary amines. More than 50 examples achieved with a broad range scope validate the universal applicability of this mild and sustainable coupling approach. The synthetic utility of this protocol was further demonstrated by the synthesis of existing pharmaceuticals via selective N-alkylation of amines. This strategy based on the sustainable water splitting technology highlights a significant and promising route for selective synthesis of valuable N-alkylated fine chemicals and pharmaceuticals from nitroarenes and amines with water and alkanols.

Method for reducing residues of N-ethyl-3-phenylpropylamine in alverine

-

Paragraph 0055; 0060; 0061, (2018/11/03)

The invention relates to a method for reducing residues of N-ethyl-3-phenylpropylamine in alverine, and belongs to an impurity removal method of compounds. The method comprises the following steps: dissolving an intermediate alverine crude product containing impurity N-ethyl-3-phenylpropylamine into a water-insoluble organic solvent, extracting an organic layer by using an aqueous solution with appropriate pH and discarding a water layer; drying and filtering the organic layer, decompressing and evaporating the solvent to dryness. According to the method disclosed by the invention, a clear, simple and reliable solution to the residues of the N-ethyl-3-phenylpropylamine in the intermediate alverine is provided for the first time, so that the subsequently produced crude drug citric acid alverine has higher quality and the residue amount does not exceed 0.15 percent. The method has the advantages of simplicity, feasibility, low cost, few wastes and suitability for industrial popularization.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 150-59-4